Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARWR Arrowhead Research Corporation

未开盘 09-18 16:00:00 EDT

31.51

+2.38

+8.17%

盘后31.77

+0.26+0.83%

19:58 EDT

最高31.62	最低29.81	成交量275.87万
今开29.85	昨收29.13	日振幅6.21%
总市值43.56亿	流通市值37.47亿	总股本1.38亿
成交额8,580万	换手率2.32%	流通股本1.19亿
市净率8.34	ROE-37.11%	每股收益-1.14
52周最高31.62	52周最低9.57	市盈率-27.68
股息0.00	股息收益率0.00	ROA-5.96%

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Research Corporation","latestPrice":31.51,"timestamp":1758225600000,"preClose":29.13,"halted":0,"volume":2758657,"hourTrading":{"tag":"盘后","latestPrice":31.77,"preClose":31.51,"latestTime":"19:58 EDT","volume":164770,"amount":5192103.7792,"timestamp":1758239888605},"delay":0,"floatShares":118912525,"shares":138257550,"eps":-1.138361,"marketStatus":"未开盘","change":2.38,"latestTime":"09-18 16:00:00 EDT","open":29.85,"high":31.62,"low":29.81,"amount":85804456.282842,"amplitude":0.062135,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.138361,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1758268800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":740203200000,"exchange":"NASDAQ","adjPreClose":29.13,"preHourTrading":{"tag":"盘前","latestPrice":29.85,"preClose":29.13,"latestTime":"09:29 EDT","volume":5850,"amount":172846.5102,"timestamp":1758202199999},"postHourTrading":{"tag":"盘后","latestPrice":31.77,"preClose":31.51,"latestTime":"19:58 EDT","volume":164770,"amount":5192103.7792,"timestamp":1758239888605},"volumeRatio":1.164106,"impliedVol":0.5116,"impliedVolPercentile":0.444},"requestUrl":"/m/hq/s/ARWR","defaultTab":"news","newsList":[{"id":"2567327175","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567327175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567327175?lang=zh_cn&edition=full","pubTime":"2025-09-16 02:26","pubTimestamp":1757960795,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日02时26分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.01%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Metavia Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Salarius Pharmaceuticals, Inc.、Metavia Inc.、Atyr Pharma, Inc.较为活跃，换手率分别为577.39%、168.44%、133.08%，振幅较大的相关个股有Metavia Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为108.95%、66.63%、61.75%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916022635a722ad64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916022635a722ad64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","ARWR"],"gpt_icon":0},{"id":"1112209112","title":"Arrowhead Pharmaceuticals申请监管许可，启动Aro-Mapt治疗阿尔茨海默病及其他tau蛋白病的1/2a期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1112209112","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112209112?lang=zh_cn&edition=full","pubTime":"2025-09-10 19:31","pubTimestamp":1757503870,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals已向监管机构申请许可，计划启动其药物Aro-Mapt用于治疗阿尔茨海默病及其他tau蛋白病的1/2a期临床研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4139","ARWR"],"gpt_icon":0},{"id":"2564319406","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.14%报27.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564319406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564319406?lang=zh_cn&edition=full","pubTime":"2025-09-03 21:39","pubTimestamp":1756906783,"startTime":"0","endTime":"0","summary":"北京时间2025年09月03日21时39分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.14%。截至发稿，该股报27.00美元/股，成交量22.6617万股，换手率0.16%，振幅5.14%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Shattuck Labs, Inc.、Relmada Therapeutics, Inc.涨幅较大，Promis Neurosciences Inc.、Novabay Pharmaceuticals, Inc.、Artelo Biosciences, Inc.较为活跃，换手率分别为77.25%、36.66%、20.84%，振幅较大的相关个股有Relmada Therapeutics, Inc.、Shattuck Labs, Inc.、Artelo Biosciences, Inc.，振幅分别为18.31%、17.82%、16.35%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903213943a4b1f04e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903213943a4b1f04e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","ARWR"],"gpt_icon":0},{"id":"1158531109","title":"Arrowhead Pharmaceuticals盘前股价上涨1.2%，此前公司与Novartis就神经肌肉疗法许可达成20亿美元协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1158531109","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158531109?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:31","pubTimestamp":1756816279,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals股价在盘前交易中上涨1.2%，此前该公司与Novartis签署了一项价值20亿美元的神经肌肉疗法许可协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","ARWR","BK4585"],"gpt_icon":0},{"id":"1128145583","title":"异动解读 | 业绩不及预期，Arrowhead Research Corporation股价盘中大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128145583","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128145583?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:56","pubTimestamp":1754661406,"startTime":"0","endTime":"0","summary":"生物制药公司Arrowhead Research Corporation今日盘中大跌5.21%，引发投资者关注。这一显著跌幅主要源于公司最新公布的季度财报未能达到市场预期。根据Arrowhead Pharmaceuticals Inc发布的财报显示，截至6月30日的季度调整后每股亏损为1.26美元，虽然相比去年同期的每股亏损1.38美元有所改善，但仍高于分析师平均预期的每股亏损1.03美元。尽管短期内股价承压，但分析师对Arrowhead Pharmaceuticals Inc的长期前景仍持乐观态度。华尔街给予Arrowhead Pharmaceuticals Inc的12个月目标价中位数为39.50美元，较其最新收盘价16.06美元高出约59.3%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARWR"],"gpt_icon":0},{"id":"2557527259","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.04%报15.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557527259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557527259?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:36","pubTimestamp":1754660218,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时36分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.04%。截至发稿，该股报15.25美元/股，成交量12.6659万股，换手率0.09%，振幅3.42%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Bioxcel Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Onconetix, Inc.、Biovie Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为88.31%、87.34%、76.22%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cognition Therapeutics, Inc.、Bioxcel Therapeutics, Inc.，振幅分别为35.00%、26.50%、18.16%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213658a47d5d42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213658a47d5d42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ARWR","BK4588"],"gpt_icon":0},{"id":"1188417051","title":"Arrowhead 2025财年Q3业绩会总结及问答精华：临床进展与市场准备推动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1188417051","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188417051?lang=zh_cn&edition=full","pubTime":"2025-08-08 06:33","pubTimestamp":1754605994,"startTime":"0","endTime":"0","summary":"管理层对Sarepta履行财务和商业义务充满信心，并认为这将为Arrowhead提供资金支持。预计Q4将确认1亿美元的里程碑付款。问题5：Sarepta持有Arrowhead股票的计划是什么？回答：现金将进入Vicerna，部分将分配给股东，Arrowhead持有56%的股份。Arrowhead Pharmaceuticals在临床试验和市场准备方面取得了显著进展，特别是在心血管和肥胖领域的RNAi技术应用。公司与Sarepta的合作为其提供了重要的资金支持，预计未来将有多个项目进入市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"gpt_icon":0},{"id":"2551194869","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.00%报17.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551194869?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:55","pubTimestamp":1752605757,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日02时55分，Arrowhead Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.00%。截至发稿，该股报17.68美元/股，成交量63.4955万股，换手率0.46%，振幅6.50%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3520.75%、2114.80%、1562.50%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为444.11%、116.77%、75.50%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716025557a44cef2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716025557a44cef2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ARWR","BK4139","BK4588"],"gpt_icon":0},{"id":"2550823527","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550823527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550823527?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:49","pubTimestamp":1751996955,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日01时49分，Arrowhead Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.11%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Zyversa Therapeutics, Inc.、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为4001.70%、620.69%、341.39%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为146.75%、73.81%、70.97%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709014916a43e82f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709014916a43e82f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2548814114","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.07%报16.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548814114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548814114?lang=zh_cn&edition=full","pubTime":"2025-07-03 01:54","pubTimestamp":1751478892,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日01时54分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.07%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Nutriband Inc C/Wts 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为2515.91%、2036.48%、1250.78%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为1145.92%、393.59%、152.07%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070301545297978f8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070301545297978f8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ARWR","BK4139","BK4588"],"gpt_icon":0},{"id":"2539326194","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539326194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539326194?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:53","pubTimestamp":1748530430,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时53分，Arrowhead Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.01%。截至发稿，该股报16.34美元/股，成交量30.5751万股，换手率0.22%，振幅5.08%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Alzamend Neuro, Inc.、Oric Pharmaceuticals, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，Alzamend Neuro, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为7792.42%、530.23%、381.34%，振幅较大的相关个股有Alzamend Neuro, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为61.45%、52.38%、50.55%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529225350a6f20566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529225350a6f20566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ALZN","BK4539","ARWR","BK4139","BK4588"],"gpt_icon":0},{"id":"2536594142","title":"Arrowhead Pharmaceuticals, Inc.2025财年第一财季实现净利润3.70亿美元，同比增加396.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594142","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594142?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584052,"startTime":"0","endTime":"0","summary":"5月19日，Arrowhead Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第一财季净利润为3.70亿美元，同比增加396.00%；其中营业收入为5.43亿美元，每股基本收益为2.78美元。从资产负债表来看，Arrowhead Pharmaceuticals, Inc.总负债8.89亿美元，其中短期债务71.78百万美元，资产负债比为1.77，流动比率为5.14。机构评级：截至2025年5月19日，当前有13家机构对Arrowhead Pharmaceuticals, Inc.目标价做出预测，其中目标均价为42.31美元，其中最低目标价为17.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000257a6e3a78a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000257a6e3a78a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR"],"gpt_icon":0},{"id":"1166215888","title":"异动解读 | 业绩超预期，Arrowhead Pharmaceuticals盘中大涨12.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166215888","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166215888?lang=zh_cn&edition=full","pubTime":"2025-05-16 14:53","pubTimestamp":1747378399,"startTime":"0","endTime":"0","summary":"生物技术公司Arrowhead Pharmaceuticals周二盘中股价大涨12.74%，主要受到该公司最新季度财报超出市场预期的推动。根据公司公布的财报，截至3月31日的季度中，Arrowhead Pharmaceuticals实现调整后每股收益2.75美元，远超分析师平均预期的每股亏损0.20美元。这一出色的业绩表现令投资者感到惊喜，推动公司股价在盘中交易中显著上涨。值得注意的是，尽管公司业绩表现亮眼，加拿大皇家银行仍将Arrowhead Pharmaceuticals的目标价从42美元下调至40美元。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARWR"],"gpt_icon":0},{"id":"2535087937","title":"花旗：维持Arrowhead Pharma评级，由中性调整至中性评级, 目标价由21.00美元调整至17.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535087937","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535087937?lang=zh_cn&edition=full","pubTime":"2025-05-14 03:29","pubTimestamp":1747164594,"startTime":"0","endTime":"0","summary":"花旗：维持Arrowhead Pharma(ARWR.US)评级，由中性调整至中性评级, 目标价由21.00美元调整至17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051403341194f5e29c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051403341194f5e29c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR"],"gpt_icon":0},{"id":"1185804887","title":"异动解读 | 业绩超预期，Arrowhead Pharmaceuticals盘中大涨12.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185804887","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185804887?lang=zh_cn&edition=full","pubTime":"2025-05-13 21:34","pubTimestamp":1747143265,"startTime":"0","endTime":"0","summary":"生物技术公司Arrowhead Pharmaceuticals周二盘中股价大涨12.74%，主要受到该公司最新季度财报超出市场预期的推动。根据公司公布的财报，截至3月31日的季度中，Arrowhead Pharmaceuticals实现调整后每股收益2.75美元，远超分析师平均预期的每股亏损0.20美元。这一出色的业绩表现令投资者感到惊喜，推动公司股价在盘中交易中显著上涨。值得注意的是，尽管公司业绩表现亮眼，加拿大皇家银行仍将Arrowhead Pharmaceuticals的目标价从42美元下调至40美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARWR"],"gpt_icon":0},{"id":"1192967395","title":"异动解读 | 业绩超预期，Arrowhead Pharmaceuticals盘前大涨10.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192967395","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192967395?lang=zh_cn&edition=full","pubTime":"2025-05-13 16:14","pubTimestamp":1747124087,"startTime":"0","endTime":"0","summary":"生物技术公司Arrowhead Pharmaceuticals周二盘前股价大涨10.02%，主要受到该公司最新季度财报超出市场预期的推动。根据公司公布的财报，截至3月31日的季度中，Arrowhead Pharmaceuticals实现调整后每股收益2.75美元，远超分析师平均预期的每股亏损0.20美元。这一出色的业绩表现令投资者感到惊喜，推动公司股价在盘前交易中显著上涨。值得注意的是，尽管公司业绩表现亮眼，加拿大皇家银行仍将Arrowhead Pharmaceuticals的目标价从42美元下调至40美元。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"异动解读 | 业绩超预期，Arrowhead Pharmaceuticals盘前大涨10.02%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARWR"],"gpt_icon":0},{"id":"2533542416","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533542416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533542416?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:48","pubTimestamp":1746546527,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时48分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.01%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为4.83%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Liminatus Pharma Inc C/Wts 30/04/2030 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为7652.38%、1176.74%、461.19%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为158.45%、42.31%、39.52%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062348479750dacd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062348479750dacd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ARWR","KTTA","BK4588","BK4139"],"gpt_icon":0},{"id":"2532262823","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报14.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532262823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532262823?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:01","pubTimestamp":1746198075,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日23时01分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.03%。截至发稿，该股报14.75美元/股，成交量25.8123万股，换手率0.19%，振幅3.85%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Polyrizon Ltd.、Impact Biomedical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃，换手率分别为745.82%、617.42%、517.39%，振幅较大的相关个股有Polyrizon Ltd.、Impact Biomedical, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为267.88%、112.75%、71.36%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502230115a6d12c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502230115a6d12c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","BK4007","IBO","ARWR"],"gpt_icon":0},{"id":"2532643770","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532643770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532643770?lang=zh_cn&edition=full","pubTime":"2025-05-01 02:20","pubTimestamp":1746037216,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日02时20分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.01%。截至发稿，该股报14.15美元/股，成交量77.9398万股，换手率0.57%，振幅8.31%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nutriband Inc.涨幅较大，Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃，换手率分别为164.26%、41.21%、37.10%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为64.00%、37.52%、34.25%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501022016aa2c8013&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501022016aa2c8013&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ARWR","BK4588","BK4139"],"gpt_icon":0},{"id":"2529148383","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529148383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529148383?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:24","pubTimestamp":1745245463,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时24分，Arrowhead Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.52%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.涨幅较大，Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为1013.34%、710.97%、530.53%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为106.34%、58.81%、43.24%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222424a4612c1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222424a4612c1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","ARWR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arrowheadpharma.com","stockEarnings":[{"period":"1week","weight":0.0083},{"period":"1month","weight":0.4631},{"period":"3month","weight":0.8649},{"period":"6month","weight":0.9682},{"period":"1year","weight":0.4558},{"period":"ytd","weight":0.5495}],"compareEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":0.0247},{"period":"3month","weight":0.1033},{"period":"6month","weight":0.1688},{"period":"1year","weight":0.1707},{"period":"ytd","weight":0.1247}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立，后在特拉华州重新注册成立。该公司开发药物，通过沉默疾病的基因来治疗疑难杂症。使用广泛的RNA化学组合和高效的递送模式，该公司的疗法触发RNA干扰机制，以诱导目标基因的快速、深度和持久敲低。该公司已将资源集中于在跨越多个治疗领域的多个动物模型中独家利用其高水平药理活性的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.47619,"avgChangeRate":0.008191},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.00488},{"month":3,"riseRate":0.52381,"avgChangeRate":0.053201},{"month":4,"riseRate":0.47619,"avgChangeRate":0.025874},{"month":5,"riseRate":0.380952,"avgChangeRate":0.008317},{"month":6,"riseRate":0.571429,"avgChangeRate":0.023453},{"month":7,"riseRate":0.571429,"avgChangeRate":0.054423},{"month":8,"riseRate":0.428571,"avgChangeRate":0.013202},{"month":9,"riseRate":0.52381,"avgChangeRate":0.052545},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.040731},{"month":11,"riseRate":0.52381,"avgChangeRate":0.052244},{"month":12,"riseRate":0.428571,"avgChangeRate":0.045143}],"exchange":"NASDAQ","name":"Arrowhead Research Corporation","nameEN":"Arrowhead Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arrowhead Research Corporation,ARWR,Arrowhead Research Corporation股票,Arrowhead Research Corporation股票老虎,Arrowhead Research Corporation股票老虎国际,Arrowhead Research Corporation行情,Arrowhead Research Corporation股票行情,Arrowhead Research Corporation股价,Arrowhead Research Corporation股市,Arrowhead Research Corporation股票价格,Arrowhead Research Corporation股票交易,Arrowhead Research Corporation股票购买,Arrowhead Research Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}